STOCK TITAN

Nov Inc Financials

NOV
FY2025 annual
Revenue $8.7B -1.4% YoY
Net Income $145.0M -77.2% YoY
EPS (Diluted) $0.39 -75.6% YoY
Free Cash Flow $876.0M -8.1% YoY
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

Nov Inc (NOV) reported $8.7B in revenue for fiscal year 2025, down 1.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NOV FY2025

Working-capital release kept cash generation strong even as margin compression pushed FY2025 earnings sharply lower.

From FY2024 to FY2025, net income fell from $635M to $145M, a much steeper drop than the change in sales or free cash generation would suggest. Yet free cash flow still held at $876M while inventory ended lower at $1.80B, implying working capital released cash and made FY2025 profit look softer than the business’s cash extraction from operations.

With sales roughly flat, gross margin slipped to 20.2% and operating margin to 5.7% in FY2025, so the profit squeeze came from weaker margin capture rather than a demand collapse. That reversal from FY2024’s stronger margin shape shows how quickly a modest top-line stall can compress profit in this cost structure.

Cash at $1.55B sits close to long-term debt of $1.69B, while liquidity stayed comfortable at 2.4x current ratio, indicating a balanced balance-sheet posture rather than one propped up by borrowings. Because leverage stayed broadly steady across the last three years, free cash flow of $876M covering buybacks and dividends reads as genuine self-funding rather than payout support from new debt.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 57 / 100
Financial Health Score 57/100
Scored as: Energy peer group

Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Nov Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
35
Growth
46
Leverage
78
Liquidity
81
Cash Flow
58
Returns
44
Altman Z-Score Grey Zone
2.08

Nov Inc scores 2.08, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

Nov Inc passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
8.63x

For every $1 of reported earnings, Nov Inc generates $8.63 in operating cash flow ($1.3B OCF vs $145.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
5.61x

Nov Inc earns $5.61 in operating income for every $1 of interest expense ($494.0M vs $88.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$8.7B
YoY-1.4%
5Y CAGR+7.5%
10Y CAGR-5.1%

Nov Inc generated $8.7B in revenue in fiscal year 2025. This represents a decrease of 1.4% from the prior year.

EBITDA
$849.0M
YoY-30.4%
10Y CAGR+9.0%

Nov Inc's EBITDA was $849.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 30.4% from the prior year.

Net Income
$145.0M
YoY-77.2%

Nov Inc reported $145.0M in net income in fiscal year 2025. This represents a decrease of 77.2% from the prior year.

EPS (Diluted)
$0.39
YoY-75.6%

Nov Inc earned $0.39 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 75.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$876.0M
YoY-8.1%
5Y CAGR+4.6%
10Y CAGR0.0%

Nov Inc generated $876.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 8.1% from the prior year.

Cash & Debt
$1.6B
YoY+26.2%
5Y CAGR-1.7%
10Y CAGR-2.9%

Nov Inc held $1.6B in cash against $1.7B in long-term debt as of fiscal year 2025.

Dividends Per Share
$0.51
YoY+85.5%
5Y CAGR+59.1%
10Y CAGR-12.0%

Nov Inc paid $0.51 per share in dividends in fiscal year 2025. This represents an increase of 85.5% from the prior year.

Shares Outstanding
360M
YoY-5.4%
5Y CAGR-1.5%
10Y CAGR-0.4%

Nov Inc had 360M shares outstanding in fiscal year 2025. This represents a decrease of 5.4% from the prior year.

Margins & Returns

Gross Margin
20.2%
YoY-2.4pp
5Y CAGR+13.1pp
10Y CAGR-0.6pp

Nov Inc's gross margin was 20.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.4 percentage points from the prior year.

Operating Margin
5.7%
YoY-4.2pp
5Y CAGR+45.5pp
10Y CAGR+8.3pp

Nov Inc's operating margin was 5.7% in fiscal year 2025, reflecting core business profitability. This is down 4.2 percentage points from the prior year.

Net Margin
1.7%
YoY-5.5pp
5Y CAGR+43.4pp
10Y CAGR+6.9pp

Nov Inc's net profit margin was 1.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 5.5 percentage points from the prior year.

Return on Equity
2.3%
YoY-7.6pp
5Y CAGR+51.1pp
10Y CAGR+7.0pp

Nov Inc's ROE was 2.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 7.6 percentage points from the prior year.

Capital Allocation

Share Buybacks
$315.0M
YoY+37.6%

Nov Inc spent $315.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 37.6% from the prior year.

Capital Expenditures
$375.0M
YoY+6.8%
5Y CAGR+10.7%
10Y CAGR-1.9%

Nov Inc invested $375.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 6.8% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

NOV Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

NOV annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$8.7B$8.7B-1.4%$8.9B+3.3%$8.6B+18.6%$7.2B+31.0%$5.5B-9.3%$6.1B-28.2%$8.5B+0.3%$8.5B+15.7%$7.3B+0.7%$7.3B-50.9%$14.8B-31.2%$21.4B+11.5%$19.2B+11.8%$17.2B+27.6%$13.5B
Cost of Revenue$7.0B$7.0B+1.7%$6.9B+1.6%$6.8B+14.3%$5.9B+24.3%$4.8B-16.0%$5.7B-25.9%$7.6B+8.9%$7.0B+9.3%$6.4B-12.8%$7.4B-37.1%$11.7B-25.2%$15.6B+10.7%$14.1B+16.2%$12.2B+32.4%$9.2B
Gross Profit$1.7B$1.8B-12.1%$2.0B+9.7%$1.8B+37.4%$1.3B+72.4%$774.0M+78.3%$434.0M-48.6%$845.0M-41.5%$1.4B+61.9%$892.0M+983.2%-$101.0M-103.3%$3.1B-47.3%$5.8B+13.8%$5.1B+1.2%$5.0B+17.4%$4.3B
SG&A Expenses$1.2B$1.2B+6.1%$1.1B-4.1%$1.2B+10.5%$1.1B+17.8%$908.0M-6.2%$968.0M-25.7%$1.3B+5.7%$1.2B+5.5%$1.2B-12.6%$1.3B-24.1%$1.8B-15.7%$2.1B+9.8%$1.9B+15.2%$1.7B+11.2%$1.5B
Operating Income$389.0M$494.0M-43.6%$876.0M+34.6%$651.0M+146.6%$264.0M+297.0%-$134.0M+94.5%-$2.4B+61.4%-$6.3B-3075.8%$211.0M+176.2%-$277.0M+88.5%-$2.4B-518.2%-$390.0M-110.8%$3.6B+12.9%$3.2B-5.6%$3.4B+20.6%$2.8B
Interest Expense$88.0M$88.0M-3.3%$91.0M+3.4%$88.0M+12.8%$78.0M+1.3%$77.0M-8.3%$84.0M-16.0%$100.0M+7.5%$93.0M-8.8%$102.0M-2.9%$105.0M+1.9%$103.0M-1.9%$105.0M-5.4%$111.0M+126.5%$49.0M+22.5%$40.0M
Income Tax$192.0M$224.0M+14.3%$196.0M+152.5%-$373.0M-549.4%$83.0M+453.3%$15.0M+106.2%-$242.0M+34.4%-$369.0M-685.7%$63.0M+140.4%-$156.0M+24.6%-$207.0M-216.3%$178.0M-82.9%$1.0B+10.2%$943.0M-2.3%$965.0M+7.9%$894.0M
Net Income$91.0M$145.0M-77.2%$635.0M-36.1%$993.0M+540.6%$155.0M+162.0%-$250.0M+90.2%-$2.5B+58.3%-$6.1B-19561.3%-$31.0M+86.9%-$237.0M+90.2%-$2.4B-213.7%-$769.0M-130.7%$2.5B+7.5%$2.3B-6.6%$2.5B+24.9%$2.0B
EPS (Diluted)$0.39-75.6%$1.60-36.0%$2.50+541.0%$0.39+160.0%-$0.65+90.2%-$6.62+58.5%-$15.96-19850.0%-$0.08+87.3%-$0.63+90.2%-$6.41-222.1%-$1.99-134.2%$5.82+7.0%$5.44-6.7%$5.83+24.0%$4.70

Not reported in any period shown, so not listed: R&D Expenses.

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

NOV Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

NOV annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$11.3B-0.6%$11.4B+0.6%$11.3B+11.4%$10.1B+6.1%$9.6B-3.8%$9.9B-24.5%$13.1B-33.6%$19.8B-2.0%$20.2B-4.4%$21.1B-18.6%$26.0B-22.6%$33.6B-3.6%$34.8B+10.6%$31.5B+23.4%$25.5B
Current Assets$5.8B+0.9%$5.8B-1.2%$5.8B+6.3%$5.5B+12.1%$4.9B-5.9%$5.2B-14.8%$6.1B-16.0%$7.3B+0.9%$7.2B-8.4%$7.9B-31.1%$11.4B-29.3%$16.2B-1.6%$16.4B+4.8%$15.7B+29.5%$12.1B
Cash & Equivalents$1.6B+26.2%$1.2B+50.7%$816.0M-23.7%$1.1B-32.8%$1.6B-6.0%$1.7B+44.5%$1.2B-17.9%$1.4B-0.7%$1.4B+2.1%$1.4B-32.3%$2.1B-41.2%$3.5B+2.9%$3.4B+3.5%$3.3B-6.1%$3.5B
Inventory$1.8B-6.9%$1.9B-10.2%$2.2B+18.6%$1.8B+36.2%$1.3B-5.5%$1.4B-35.9%$2.2B-26.4%$3.0B-0.6%$3.0B-9.7%$3.3B-28.9%$4.7B-11.4%$5.3B-5.7%$5.6B-4.9%$5.9B+46.2%$4.0B
Goodwill$1.6B-2.9%$1.6B+4.4%$1.6B+3.8%$1.5B-1.4%$1.5B+2.3%$1.5B-46.8%$2.8B-55.2%$6.3B+0.6%$6.2B+2.6%$6.1B-13.1%$7.0B-18.3%$8.5B-5.6%$9.0B+26.2%$7.2B+16.6%$6.2B
Total Liabilities$5.0B+0.7%$4.9B-2.4%$5.1B+1.0%$5.0B+11.5%$4.5B-3.5%$4.7B-12.3%$5.3B-10.2%$5.9B-2.3%$6.0B-15.3%$7.1B-25.0%$9.5B-25.6%$12.8B+2.5%$12.5B+12.2%$11.1B+42.9%$7.8B
Current Liabilities$2.4B+2.5%$2.3B-3.6%$2.4B-0.1%$2.4B+27.6%$1.9B+2.3%$1.9B-16.9%$2.2B-4.0%$2.3B-0.6%$2.4B-22.7%$3.0B-23.0%$4.0B-46.3%$7.4B+10.4%$6.7B+18.2%$5.6B+4.3%$5.4B
Long-Term Debt$1.7B-0.9%$1.7B-0.5%$1.7B-0.3%$1.7B+0.5%$1.7B-6.9%$1.8B-7.8%$2.0B-19.9%$2.5B-8.3%$2.7B-0.1%$2.7B-30.7%$3.9B+29.6%$3.0B-4.3%$3.1B0.0%$3.1B+1879.9%$159.0M
Total Equity$6.3B-1.7%$6.4B+3.4%$6.2B+21.0%$5.1B+2.0%$5.0B-4.1%$5.2B-33.0%$7.8B-43.7%$13.8B-2.0%$14.1B+1.1%$13.9B-14.9%$16.4B-20.8%$20.7B-6.9%$22.2B+9.8%$20.2B+14.9%$17.6B
Retained Earnings-$673.0M-7.2%-$628.0M+45.6%-$1.2B+44.2%-$2.1B+3.6%-$2.1B-14.4%-$1.9B-371.9%$690.0M-89.9%$6.9B-1.5%$7.0B-4.4%$7.3B-26.6%$9.9B-24.7%$13.2B-1.1%$13.3B+17.0%$11.4B+25.1%$9.1B

Not reported in any period shown, so not listed: Accounts Receivable.

NOV Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

NOV annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$1.1B$1.3B-4.1%$1.3B+811.9%$143.0M+179.9%-$179.0M-161.5%$291.0M-68.6%$926.0M+29.7%$714.0M+37.0%$521.0M-37.4%$832.0M-13.3%$960.0M-27.9%$1.3B-49.0%$2.6B-23.0%$3.4B+447.9%$620.0M-71.1%$2.1B
Capital Expenditures$356.0M$375.0M+6.8%$351.0M+24.0%$283.0M+32.2%$214.0M+6.5%$201.0M-11.1%$226.0M-3.0%$233.0M-4.5%$244.0M+27.1%$192.0M-32.4%$284.0M-37.3%$453.0M-35.2%$699.0M+13.8%$614.0M+7.9%$569.0M+18.8%$479.0M
Free Cash Flow$734.0M$876.0M-8.1%$953.0M+780.7%-$140.0M+64.4%-$393.0M-536.7%$90.0M-87.1%$700.0M+45.5%$481.0M+73.6%$277.0M-56.7%$640.0M-5.3%$676.0M-23.1%$879.0M-54.1%$1.9B-31.2%$2.8B+5356.9%$51.0M-96.9%$1.7B
Investing Cash Flow-$345.0M-$362.0M+23.1%-$471.0M-60.8%-$293.0M-23.1%-$238.0M-21.4%-$196.0M-36.1%-$144.0M+54.3%-$315.0M+31.1%-$457.0M-86.5%-$245.0M+49.8%-$488.0M+5.1%-$514.0M+53.4%-$1.1B+62.8%-$3.0B+13.5%-$3.4B-135.1%-$1.5B
Financing Cash Flow-$564.0M-$584.0M-43.8%-$406.0M-294.2%-$103.0M-7.3%-$96.0M+49.2%-$189.0M+27.0%-$259.0M+60.0%-$647.0M-2056.7%-$30.0M+95.0%-$595.0M+47.9%-$1.1B+47.2%-$2.2B-61.1%-$1.3B-340.3%-$305.0M-111.8%$2.6B+656.7%-$464.0M
Dividends Paid$195.0M$190.0M+75.9%$108.0M+36.7%$79.0M+1.3%$78.0M+290.0%$20.0M+5.3%$19.0M-75.3%$77.0M+1.3%$76.0M0.0%$76.0M-67.0%$230.0M-67.6%$710.0M+1.0%$703.0M+80.7%$389.0M+86.1%$209.0M+9.4%$191.0M
Share Buybacks$301.0M$315.0M+37.6%$229.0MN/AN/AN/AN/AN/AN/AN/AN/A$2.2B+185.1%$779.0MN/AN/AN/A

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

NOV Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

NOV annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin20.2%-2.4pp22.7%+1.3pp21.4%+2.9pp18.4%+4.4pp14.0%+6.9pp7.1%-2.8pp10.0%-7.1pp17.1%+4.9pp12.2%+13.6pp-1.4%-22.1pp20.8%-6.3pp27.1%+0.5pp26.6%-2.8pp29.3%-2.5pp31.9%
Operating Margin5.7%-4.2pp9.9%+2.3pp7.6%+3.9pp3.6%+6.1pp-2.4%+37.4pp-39.8%+34.2pp-74.1%-76.6pp2.5%+6.3pp-3.8%+29.5pp-33.3%-30.6pp-2.6%-19.5pp16.9%+0.2pp16.6%-3.1pp19.7%-1.1pp20.8%
Net Margin1.7%-5.5pp7.2%-4.4pp11.6%+9.4pp2.1%+6.7pp-4.5%+37.2pp-41.7%+30.1pp-71.9%-71.5pp-0.4%+2.9pp-3.2%+30.0pp-33.3%-28.1pp-5.2%-16.9pp11.7%-0.4pp12.1%-2.4pp14.5%-0.3pp14.8%
Return on Equity2.3%-7.6pp10.0%-6.1pp16.1%+13.1pp3.0%+8.0pp-5.0%+43.8pp-48.8%+29.6pp-78.4%-78.1pp-0.2%+1.5pp-1.7%+15.6pp-17.3%-12.6pp-4.7%-16.8pp12.1%+1.6pp10.5%-1.8pp12.3%+1.0pp11.3%
Return on Assets1.3%-4.3pp5.6%-3.2pp8.8%+7.3pp1.5%+4.2pp-2.6%+23.0pp-25.6%+20.8pp-46.4%-46.2pp-0.2%+1.0pp-1.2%+10.2pp-11.4%-8.4pp-3.0%-10.4pp7.4%+0.8pp6.7%-1.2pp7.9%+0.1pp7.8%
Current Ratio2.420.0x2.46+0.1x2.40+0.1x2.25-0.3x2.57-0.2x2.79+0.1x2.72-0.4x3.110.0x3.07+0.5x2.58-0.3x2.89+0.7x2.19-0.3x2.46-0.3x2.78+0.5x2.24
Debt-to-Equity0.270.0x0.270.0x0.28-0.1x0.340.0x0.340.0x0.35+0.1x0.26+0.1x0.180.0x0.190.0x0.190.0x0.24+0.1x0.150.0x0.140.0x0.16+0.1x0.01
FCF Margin10.0%-0.7pp10.7%+12.4pp-1.6%+3.8pp-5.4%-7.1pp1.6%-9.9pp11.5%+5.8pp5.7%+2.4pp3.3%-5.5pp8.8%-0.6pp9.3%+3.4pp6.0%-3.0pp8.9%-5.6pp14.5%+14.2pp0.3%-12.0pp12.3%

Similar Companies

Frequently Asked Questions

What is Nov Inc's annual revenue?

Nov Inc (NOV) reported $8.7B in total revenue for fiscal year 2025. This represents a -1.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Nov Inc's revenue growing?

Nov Inc (NOV) revenue declined by 1.4% year-over-year, from $8.9B to $8.7B in fiscal year 2025.

Is Nov Inc profitable?

Yes, Nov Inc (NOV) reported a net income of $145.0M in fiscal year 2025, with a net profit margin of 1.7%.

Nov Inc (NOV) reported diluted earnings per share of $0.39 for fiscal year 2025. This represents a -75.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Nov Inc (NOV) had EBITDA of $849.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Nov Inc (NOV) had $1.6B in cash and equivalents against $1.7B in long-term debt.

Nov Inc (NOV) had a gross margin of 20.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Nov Inc (NOV) had an operating margin of 5.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Nov Inc (NOV) had a net profit margin of 1.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Nov Inc (NOV) paid $0.51 per share in dividends during fiscal year 2025.

Nov Inc (NOV) has a return on equity of 2.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Nov Inc (NOV) generated $876.0M in free cash flow during fiscal year 2025. This represents a -8.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Nov Inc (NOV) generated $1.3B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Nov Inc (NOV) had $11.3B in total assets as of fiscal year 2025, including both current and long-term assets.

Nov Inc (NOV) invested $375.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Nov Inc (NOV) spent $315.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Nov Inc (NOV) had 360M shares outstanding as of fiscal year 2025.

Nov Inc (NOV) had a current ratio of 2.42 as of fiscal year 2025, which is generally considered healthy.

Nov Inc (NOV) had a debt-to-equity ratio of 0.27 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Nov Inc (NOV) had a return on assets of 1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Nov Inc (NOV) has an Altman Z-Score of 2.08, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Nov Inc (NOV) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Nov Inc (NOV) has an earnings quality ratio of 8.63x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Nov Inc (NOV) has an interest coverage ratio of 5.61x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Nov Inc (NOV) scores 57 out of 100 on our Financial Health Score, indicating moderate standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top